PIMREG and pancreatic neoplasm: In previous studies, it was reported that CatS participates in the degradation of E-cadherin—proven via a mouse model of pancreatic cancer [41]—and may mediate blood–brain barrier transmigration through the proteolytic processing of JAM-B-favoring brain metastasis [42].